Global Formulation Development Outsourcing Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Formulation development is a method of determining the lifecycle, patentability, and accomplishment of the pharmaceutical product. This process includes pre-formulation such as excipient screening to stabilize, analytical assay development & characterization. Formulation development outsourcing provides a wide range of benefits, such as accessing expertise, compressing timelines, and giving extra insurance against product failure. The thriving growth of the pharmaceutical & biotechnology sector, increasing cost-effectiveness of formulation outsourcing services, and the growing trend of patent protection expiration of major drugs are the primary factors impelling the global market demand. For instance, according to the Indian Brand Equity Foundation (IBEF), in India, the pharmaceutical market was estimated to be worth around USD 42 billion in 2021. Also, it is anticipated that the market progressively grows and reach nearly 130 billion by 2030. Accordingly, the flourishing development of the pharmaceutical sector is excelling the growth of the market around the world. However, structural changes in the pharmaceutical industry and insufficient funding to perform the drug development process through formulation development impede the growth of the market over the forecast period of 2022-2028. Also, the rising R&D spending and substantial development of the emerging markets are anticipated to act as catalyzing factors for the market demand during the forecast period.
The key regions considered for the global Formulation Development Outsourcing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the rapid adoption of novel technologies, and the presence of various prominent market players. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing investments in research and development activities, and the growth of various emerging markets such as South Korea, India, Japan, and China would create lucrative growth prospects for the Formulation Development Outsourcing Market across the Asia-Pacific region.
Major market players included in this report are:
SGS S.A.
Intertek Group plc
Recipharm
Lonza
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Element
Labcorp
Thermo Fisher Scientific, Inc. (Patheon)
Catalent Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Service :
Preformulation
Formulation Development
By Formulation:
Oral
Injectable
Topical
Others
By Application:
Oncology
Neurology
Infectious Disease
Cardiovascular
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Formulation Development Outsourcing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
- 1.2.1. Formulation Development Outsourcing Market, by Region, 2020-2028 (USD Million)
- 1.2.2. Formulation Development Outsourcing Market, by Service, 2020-2028 (USD Million)
- 1.2.3. Formulation Development Outsourcing Market, by Formulation, 2020-2028 (USD Million)
- 1.2.4. Formulation Development Outsourcing Market, by Application, 2020-2028 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Formulation Development Outsourcing Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Formulation Development Outsourcing Market Dynamics
- 3.1. Formulation Development Outsourcing Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Thriving growth of the pharmaceutical & biotechnology sector
- 3.1.1.2. Increasing cost-effectiveness of formulation outsourcing services
- 3.1.2. Market Challenges
- 3.1.2.1. Structural changes in the pharmaceutical industry
- 3.1.2.2. Insufficient funding to perform the drug development process through formulation development
- 3.1.3. Market Opportunities
- 3.1.3.1. Rising R&D spending
- 3.1.3.2. Substantial development of the emerging markets
Chapter 4. Global Formulation Development Outsourcing Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Formulation Development Outsourcing Market, by Service
- 6.1. Market Snapshot
- 6.2. Global Formulation Development Outsourcing Market by Service, Performance - Potential Analysis
- 6.3. Global Formulation Development Outsourcing Market Estimates & Forecasts by Service, 2018-2028 (USD Million)
- 6.4. Formulation Development Outsourcing Market, Sub Segment Analysis
- 6.4.1. Preformulation
- 6.4.2. Formulation Development
Chapter 7. Global Formulation Development Outsourcing Market, by Formulation
- 7.1. Market Snapshot
- 7.2. Global Formulation Development Outsourcing Market by Formulation, Performance - Potential Analysis
- 7.3. Global Formulation Development Outsourcing Market Estimates & Forecasts by Formulation, 2018-2028 (USD Million)
- 7.4. Formulation Development Outsourcing Market, Sub Segment Analysis
- 7.4.1. Oral
- 7.4.2. Injectable
- 7.4.3. Topical
- 7.4.4. Others
Chapter 8. Global Formulation Development Outsourcing Market, by Application
- 8.1. Market Snapshot
- 8.2. Global Formulation Development Outsourcing Market by Application, Performance - Potential Analysis
- 8.3. Global Formulation Development Outsourcing Market Estimates & Forecasts by Application, 2018-2028 (USD Million)
- 8.4. Formulation Development Outsourcing Market, Sub Segment Analysis
- 8.4.1. Oncology
- 8.4.2. Neurology
- 8.4.3. Infectious Disease
- 8.4.4. Cardiovascular
- 8.4.5. Others
Chapter 9. Global Formulation Development Outsourcing Market, Regional Analysis
- 9.1. Formulation Development Outsourcing Market, Regional Market Snapshot
- 9.2. North America Formulation Development Outsourcing Market
- 9.2.1. U.S. Formulation Development Outsourcing Market
- 9.2.1.1. Service breakdown estimates & forecasts, 2018-2028
- 9.2.1.2. Formulation breakdown estimates & forecasts, 2018-2028
- 9.2.1.3. Application breakdown estimates & forecasts, 2018-2028
- 9.2.2. Canada Formulation Development Outsourcing Market
- 9.3. Europe Formulation Development Outsourcing Market Snapshot
- 9.3.1. U.K. Formulation Development Outsourcing Market
- 9.3.2. Germany Formulation Development Outsourcing Market
- 9.3.3. France Formulation Development Outsourcing Market
- 9.3.4. Spain Formulation Development Outsourcing Market
- 9.3.5. Italy Formulation Development Outsourcing Market
- 9.3.6. Rest of Europe Formulation Development Outsourcing Market
- 9.4. Asia-Pacific Formulation Development Outsourcing Market Snapshot
- 9.4.1. China Formulation Development Outsourcing Market
- 9.4.2. India Formulation Development Outsourcing Market
- 9.4.3. Japan Formulation Development Outsourcing Market
- 9.4.4. Australia Formulation Development Outsourcing Market
- 9.4.5. South Korea Formulation Development Outsourcing Market
- 9.4.6. Rest of Asia Pacific Formulation Development Outsourcing Market
- 9.5. Latin America Formulation Development Outsourcing Market Snapshot
- 9.5.1. Brazil Formulation Development Outsourcing Market
- 9.5.2. Mexico Formulation Development Outsourcing Market
- 9.6. Rest of The World Formulation Development Outsourcing Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. SGS S.A.
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. Product Summary
- 10.2.1.5. Recent Developments
- 10.2.2. Intertek Group plc
- 10.2.3. Recipharm
- 10.2.4. Lonza
- 10.2.5. Charles River Laboratories International, Inc.
- 10.2.6. Eurofins Scientific SE
- 10.2.7. Element
- 10.2.8. Labcorp
- 10.2.9. Thermo Fisher Scientific, Inc. (Patheon)
- 10.2.10. Catalent Inc.
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption